Question 1

What are the key details for the project “Biosignature Discovery for Personalized Treatment in Depression (U01)”?

Accepted Answer

The project “Biosignature Discovery for Personalized Treatment in Depression (U01)” is an infrastructure initiative in the Power Transmission sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Question 2

What is the latest status of the project “Biosignature Discovery for Personalized Treatment in Depression (U01)”?

Accepted Answer

The status recorded for “Biosignature Discovery for Personalized Treatment in Depression (U01)” is archived.

Question 3

Who are the main government, EPC, and private stakeholders for “Biosignature Discovery for Personalized Treatment in Depression (U01)”?

Accepted Answer

Taiyo maps the stakeholders of “Biosignature Discovery for Personalized Treatment in Depression (U01)”: government bodies (National Institutes of Health (NIH), US Department of Health and Human Services (HHS), US Government).

Question 4

What is the budget and commercial profile for the project “Biosignature Discovery for Personalized Treatment in Depression (U01)”?

Accepted Answer

Taiyo normalizes the budget of “Biosignature Discovery for Personalized Treatment in Depression (U01)” to USD 6000000.

Question 5

Where can I verify the source and access all details for “Biosignature Discovery for Personalized Treatment in Depression (U01)”?

Accepted Answer

This Taiyo project page references Grants.gov along with the original URL (https://www.grants.gov/web/grants/view-opportunity.html?oppId=49463). Taiyo standardizes official data into a consistent, searchable project profile.

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Original status	archived
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description	Purpose. The purpose of this initiative is to support exploratory research to discover panels of promising biomarkers (i.e., biosignatures) that are predictive of treatment outcomes in major depressive disorder. Mechanism of Support: This FOA will utilize the NIH Cooperative Agreement (U01) award mechanism. Funds Available and Anticipated Number of Awards: The NIMH expects to commit approximately $6 million in total costs in Fiscal Year 2010 to fund one or more U01 awards under this initiative.
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Biosignature Discovery for Personalized Treatment in Depression (U01)

Project Information FAQ

Project Information